AI assistant
Sending…
Egetis Therapeutics — Major Shareholding Notification 2024
Oct 31, 2024
3152_iss_2024-10-31_d478c42b-9b30-4f59-ba11-2867bee4d911.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Issuer Egetis Therapeutics AB (publ)
Holder
Cetoros AB
Instrument
| Instrument | Aktie SE0003815604 | ||
|---|---|---|---|
| Before the transaction | |||
| Shares | 33,776,221 | ||
| Voting rights | 33,776,221 | ||
| Transaction | |||
| Reason for major shareholding notification New share issue | |||
| Date | 31/10/2024 | ||
| Limit for number of shares | 10 % | ||
| Limit for number of votes | 10 % | ||
| After the transaction | |||
| Quantity | |||
| Shares | 33,776,221 | ||
| Directly held voting rights | 33,776,221 | ||
| Indirectly held voting rights | 0 | ||
| Percentage | |||
| Directly held shares | 9.4022 % | ||
| Directly held voting rights | 9.4022 % | ||
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 9.4022 % | 33,776,221 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 9.4022 % | 33,776,221 |
| Group total holdings |
||
| Voting rights 33,776,221 |
||
| Percentage of voting rights 9.4022 | ||
| Published | ||
| 31/10/2024 04:09 | ||
| Contact | ||
| Name Peder Walberg |
||
| Phone 0703797556 |
Email [email protected] | |
| CLOSE |
||
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Egetis Therapeutics
Share Issue/Capital Change
2026
May 29
Share Issue/Capital Change
2026
May 29
Share Issue/Capital Change
2026
Apr 30
Share Issue/Capital Change
2026
Apr 30
Interim / Quarterly Report
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Share Issue/Capital Change
2026
Apr 21
Share Issue/Capital Change
2026
Apr 21
Share Issue/Capital Change
2026
Apr 21
Share Issue/Capital Change
2026
Apr 21